bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 19 citations · 55 references
MedicineMolecular BiologyMolecular MedicineEpigeneticsMolecular DiagnosticsTranscriptomicsEpigenetic Biomarker AnalysisNext-generation SequencingNucleic Acid SequencingRna ModificationRna-based DiagnosticsSequencing-based DiagnosticsDirect Rna SequencingMessenger Rna TherapeuticsMethylation DetectionNanopore SequencingRna Modification DetectionRna SequencingRna Sequencing (Rna-seq)Rna Sequencing Diagnostics
Abstract Direct RNA sequencing (DRS) is a nanopore-based technique for analyzing RNA in its native form, promising breakthroughs in diagnostics and biomarker development. Coupled to RNA002 sequencing chemistry, its clinical implementation has been challenging due to low throughput, low accuracy, and lack of large-scale RNA-modification models. In this study, we evaluate the improvements achieved by pairing the latest RNA004 chemistry with novel modified-base-calling models for pseudouridine and N 6 -methyladenosine using diverse RNA samples from cell lines, synthetic oligos, and human blood. Finally, we present the first clinical application of DRS by confirming the loss of RNA methylation in a patient carrying truncating mutations in the methyltransferase METTL5 . Conclusively, the combined use of RNA004 chemistry with the base-calling models significantly improved the throughput, accuracy, and site-specific detection of modifications. From this perspective, we offer an outlook on the potential suitability of DRS for use in routine diagnostics, the first comprehensive benchmark of human peripheral blood and quality assessments of RNA therapeutics.
55
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text